The application of the giant spheroplast for drug screening with automated planar patch clamp system.

Biotechnol Rep (Amst)

Laboratory for Drug Discovery and Glycoscience and Glycotechnology Research Group, Biotechnology Research institute for Drug Discovery, National Institute of Advanced Industrial Science and Technology (AIST), AIST Tsukuba Central 2, 1-1-1 Umezono, Tsukuba, Ibaraki 305-8568, Japan.

Published: September 2015

Kv2.1, the voltage-gated ion channel, is ubiquitously expressed in variety of tissues and dysfunction of this ion channel is responsible for multiple diseases. Electrophysiological properties of ion channels are so far characterized with eukaryotic cells using the manual patch clamp which requires skilful operators and expensive equipments. In this research, we created a simple and sensitive drug screen method using bacterial giant spheroplasts and the automated patch clamp which does not require special skills. We expressed a eukaryotic voltage-gated ion channel Kv2.1 in using prokaryotic codon, and prepared giant spheroplasts large enough for the patch clamp. Human Kv2.1 currents were successfully recorded from giant spheroplasts with the automated system, and Kv2.1-expressed spheroplasts could steadily reacted to the dose-response assay with TEA and 4-AP. Collectively, our results indicate for the first time that the bacterial giant spheroplast can be applied for practical pharmaceutical assay using the automated patch clamp.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466043PMC
http://dx.doi.org/10.1016/j.btre.2015.04.007DOI Listing

Publication Analysis

Top Keywords

patch clamp
20
ion channel
12
giant spheroplasts
12
giant spheroplast
8
voltage-gated ion
8
bacterial giant
8
spheroplasts automated
8
automated patch
8
patch
5
clamp
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!